ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 82 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,966 | -13.3% | 40,322 | +8.0% | 0.00% | – |
| Q2 2023 | $139,573 | -27.2% | 37,319 | -34.8% | 0.00% | – |
| Q1 2023 | $191,641 | +26.5% | 57,206 | +81.7% | 0.00% | – |
| Q4 2022 | $151,438 | -14.0% | 31,484 | +1.6% | 0.00% | – |
| Q3 2022 | $176,000 | -90.7% | 30,974 | -88.4% | 0.00% | -100.0% |
| Q2 2022 | $1,892,000 | +6.2% | 266,578 | +8.0% | 0.00% | 0.0% |
| Q1 2022 | $1,782,000 | +172.5% | 246,794 | +237.1% | 0.00% | – |
| Q4 2021 | $654,000 | -80.1% | 73,215 | -22.0% | 0.00% | -100.0% |
| Q3 2021 | $3,293,000 | +295.3% | 93,907 | +142.3% | 0.00% | – |
| Q2 2021 | $833,000 | +38.8% | 38,757 | +299.2% | 0.00% | – |
| Q1 2021 | $600,000 | +35.4% | 9,709 | -8.4% | 0.00% | – |
| Q4 2020 | $443,000 | – | 10,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |